Skip to main content
HOB BIOTECH GROUP CORP.,LTD. logo

HOB BIOTECH GROUP CORP.,LTD. — Investor Relations & Filings

Ticker · 688656 ISIN · CNE100004C37 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 632 across all filing types
Latest filing 2023-07-07 Declaration of Voting R…
Country CN China
Listing Shanghai Stock Exchange 688656

About HOB BIOTECH GROUP CORP.,LTD.

http://en.hob-biotech.com/

HOB Biotech Group Corp., Ltd. specializes in the development, manufacture, and distribution of in vitro diagnostic (IVD) products, with a primary focus on allergy and autoimmune disease testing. The company provides a comprehensive range of diagnostic solutions, including enzyme-linked immunosorbent assays (ELISA), line immunoassays, and advanced chemiluminescence immunoassay (CLIA) systems. Its product portfolio covers hundreds of allergens and a wide array of autoimmune markers, catering to clinical laboratories and healthcare providers. HOB Biotech is recognized for its proprietary technology platforms that enable high-throughput, automated testing, improving diagnostic efficiency and accuracy. The company's commitment to research and development supports the continuous expansion of its diagnostic menu to address evolving clinical needs in immunology and hypersensitivity.

Recent filings

Filing Released Lang Actions
江苏浩欧博生物医药股份有限公司2023年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a detailed announcement of the resolutions passed at the 2023 first extraordinary general meeting of shareholders of Jiangsu Haobo Biopharmaceutical Co., Ltd. It includes information about the meeting date, attendance, voting results for board and supervisory board elections, and legal witness statements confirming the validity of the meeting and voting process. There is no financial data or report content, but rather the official voting results and procedural details of the shareholder meeting. This matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 3126 characters, which is consistent with a detailed voting results announcement rather than a full report or presentation.
2023-07-07 Chinese
江苏浩欧博生物医药股份有限公司关于选举第三届监事会职工代表监事的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the election of a new employee representative supervisor to the company's third supervisory board. It includes details about the election process, the term of office, and the biography of the elected supervisor. There is no financial data, no mention of financial results, no regulatory filings or certifications, and no reference to annual or interim reports. The content focuses on board/management information, specifically about changes in the supervisory board composition. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication, so it is not RPA or RNS.
2023-07-05 Chinese
江苏浩欧博生物医药股份有限公司2023年第一次临时股东大会会议资料
AGM Information Classification · 95% confidence The document is titled as "2023 年第一次临时股东大会会议资料" which translates to "2023 First Extraordinary General Meeting (EGM) Meeting Materials". It contains detailed meeting instructions, agenda, and multiple proposals related to the election and re-election of board members and supervisors. The content is focused on the materials shared for the shareholders' meeting, including the agenda and proposals for voting. There is no financial data or earnings information, nor is it a report or announcement of results. The document is clearly the presentation and materials shared during a shareholders' meeting, specifically an extraordinary general meeting. Therefore, it fits the category of AGM Information (AGM-R), which also covers extraordinary general meeting materials as per the filing definitions. The document length is over 6000 characters and contains detailed meeting materials, not just an announcement or notice, so it is not a Report Publication Announcement (RPA) or Regulatory Filing (RNS).
2023-06-29 Chinese
独立董事提名人声明（黄蓉）
Board/Management Information Classification · 95% confidence The document is a nomination statement for an independent director candidate for the board of Jiangsu Haoubo Biopharmaceutical Co., Ltd. It details the qualifications, independence criteria, and compliance with relevant laws and regulations for the nominee. There is no financial data, no report or announcement of financial results, no voting results, no management changes announcement, and no regulatory filing of a different nature. This document is a formal declaration related to board/management information, specifically about the nomination of a board member. Therefore, the appropriate classification is Board/Management Information (MANG). The document length is short and focused on nomination, not a full report or announcement of a meeting or vote.
2023-06-20 Chinese
江苏浩欧博生物医药股份有限公司第二届监事会第二十一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of a supervisory board meeting resolution regarding the nomination of candidates for the next supervisory board. It includes details about the meeting date, attendance, voting results, and references to related announcements. There is no financial data, earnings information, or report publication. The content focuses on board/management changes and governance matters. Therefore, it fits best under Board/Management Information (MANG). The document length is short and it is not a report publication announcement or certification. Hence, the classification is MANG with high confidence.
2023-06-20 Chinese
独立董事提名人声明（钱跃竑）
Board/Management Information Classification · 95% confidence The document is a nomination statement for an independent director candidate for the company's board. It details the qualifications, independence criteria, and compliance with regulatory requirements for the nominee. There is no financial data, no report or announcement of financial results, no voting results, no management changes announcement, and no regulatory filing of a different nature. This document is related to board/management information specifically about the nomination of a board member. Therefore, the appropriate classification is Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication, so it is not RPA or RNS.
2023-06-20 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.